Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
|
|
News |
|
|
Catalent Buys A NJ Cell Therapy Facility For $44.5 Million.
Catalent, the high-flying CDMO, is buying a cell therapy unit on the East Coast, only days after spending $350 million to strengthen up biologics production in Indiana.
|
|
|
| |
| |
|
|
|
Carcinogen Concern Leads To Pfizer Drug Recall From The US
Pfizer's recall saga has now reached the United States, after elevated concentrations of potential carcinogens forced the company to pull multiple products in Canada.
|
|
|
| |
|
Starting The Journey Dupixent From Sanofi Puts A Good Show
Sanofi's Dupixent is still breaking new ground in inflammatory illnesses five years after receiving FDA approval for the first time in eczema. Bill Sibold, Sanofi’s global head of speciality care, believes this since the Regeneron-partnered drug’s first-quarter...
|
|
|
| |
| |
|
|
|
Rinvoq, Blockbuster Drug From Abbvie Gets Fourth FDA Nod
The pharma version of Fast and Furious has a new superhero. How else to characterise AbbVie's Rinvoq's breakthrough effectiveness. The immunology medicine received its fourth FDA approval...
|
|
|
| |
|
Camzyos, A Likely Blockbuster Heart Drug, Wins FDA Approval
Bristol Myers Squibb has gained approval for one of the year’s most anticipated medications, following a brief delay in November. Camzyos, a drug developed by Bristol Myers Squibb, was approved by the FDA...
|
|
|
| |
| |
|
|
|
Teva Settlement Stalls Austedo Generic Rollout Till 2033
Austedo, Teva's tardive dyskinesia therapy, has great prospects. Now the company only needs to worry about one less generic pharmaceutical presenting a threat to its main growth engine.
|
|
|
|
COVID-19 Updates |
|
|
60% Adults And 75% Kids Have COVID-19 Antibodies- CDC Study
According to updated information from the US Centers for Disease Control and Prevention, about 60% of adults plus 75% of children have antibodies suggesting that they've been exposed to COVID-19...
|
|
|
| | |
| |
|
|
|
Omicron Variant Descendants Begin Their Own Coronavirus Wave
The data is undeniable: COVID-19 instances and hospitalizations are on the rise in the United States, despite patchy documentation. Most states are witnessing an upsurge, with Washington, Georgia, Mississippi, South Dakota, Nevada, Maine...
|
|
|